Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
41.85
-0.06 (-0.14%)
At close: Nov 4, 2026, 4:00 PM EST
41.70
-0.15 (-0.36%)
After-hours: Nov 4, 2026, 7:57 PM EST

Teva Pharmaceutical Revenue

Teva Pharmaceutical had revenue of $4.40B in the quarter ending September 30, 2026, a decrease of -1.90%. This brings the company's total for the last twelve months to $17.23B, up 2.71% year-over-year. In the year 2025, Teva Pharmaceutical had annual revenue of $17.26B with 4.32% growth. That makes Teva Pharmaceutical the 880th largest company in the world by revenue and 296th in the United States.

Revenue (ttm)
$17.23B
Revenue Growth
+2.71%
P/S Ratio
2.83
Revenue / Employee
$507,511
Employees
33,950
Market Cap
48.83B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Revenue from Sale of Goods 14.61B 84.6%
  • Distribution 1.55B 9.0%
  • Licensing Arrangements 678.00M 3.9%
  • Other Segment 423.00M 2.5%

By Geography

Chart
  • United States 9.19B 53.2%
  • Europe 5.04B 29.2%
  • International Markets 2.16B 12.5%
  • Other Activities 870.00M 5.0%
Fiscal year ended Dec 31, 2025 See the full Teva Pharmaceutical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202517.26B714.00M4.32%
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 201916.89B-1.97B-10.43%
Dec 31, 201818.85B-3.00B-13.72%
Dec 31, 201721.85B-50.00M-0.23%
Dec 31, 201621.90B2.25B11.45%
Dec 31, 201519.65B-620.00M-3.06%
Dec 31, 201420.27B-42.00M-0.21%
Dec 31, 201320.31B-3.00M-0.01%
Dec 31, 201220.32B2.01B10.95%
Dec 31, 201118.31B2.19B13.59%
Dec 31, 201016.12B2.22B15.99%
Dec 31, 200913.90B2.81B25.39%
Dec 31, 200811.09B1.68B17.83%
Dec 31, 20079.41B1.00B11.89%
Dec 31, 20068.41B3.16B60.15%
Dec 31, 20055.25B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.